Singular Genomics Systems Inc (OMIC)
$20.01
$0.00 (0.00%)As on 21-Feb-2025 09:30EDT
Market cap
$51 Mln
Revenue (TTM)
$3 Mln
P/E Ratio
--
P/B Ratio
0.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.5 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0.8
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-34.9
-
Face value
--
-
Shares outstanding
2,537,020
5 Years Aggregate
CFO
$-248.71 Mln
EBITDA
$-275.51 Mln
Net Profit
$-322.98 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Singular Genomics Systems Inc (OMIC)
| 3.0 | 1.6 | -7.7 | 26.1 | -54.7 | -- | -- |
|
BSE Sensex*
| -9.1 | 1.1 | 1.2 | -4.8 | 5.8 | 6.6 | 10.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
|---|---|---|---|
|
Singular Genomics Systems Inc (OMIC)
| 40.4 | -77.1 | -82.6 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Singular Genomics Systems Inc (OMIC)
|
20.0 | 50.8 | 2.7 | -86.3 | -3,195.0 | -61.7 | -- | 0.4 |
| 0.0 | 0.4 | 0.8 | -12.7 | -1,153.8 | -- | -- | 11.2 |
Shareholding Pattern
View DetailsAbout Singular Genomics Systems Inc (OMIC)
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. It is involved in the developing of G4,... consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. The company was incorporated in 2016 and is based in San Diego, California. As of February 21, 2025, Singular Genomics Systems, Inc. was taken private. Read more
-
Founder, CEO, President & Chairperson of the Board
Mr. Andrew Spaventa
-
Founder, CEO, President & Chairperson of the Board
Mr. Andrew Spaventa
-
Headquarters
San Diego, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Singular Genomics Systems Inc (OMIC)
What is the current share price of Singular Genomics Systems Inc (OMIC) Today?
The share price of Singular Genomics Systems Inc (OMIC) is $20.01 (NASDAQ) as of 21-Feb-2025 09:30 EDT. Singular Genomics Systems Inc (OMIC) has given a return of -54.69% in the last 3 years.
What is the current PB & PE ratio of Singular Genomics Systems Inc (OMIC)?
Since, TTM earnings of Singular Genomics Systems Inc (OMIC) is negative, P/E ratio is not available.
The P/B ratio of Singular Genomics Systems Inc (OMIC) is 0.41 times as on 21-Feb-2025, a 92 discount to its peers’ median range of 5.35 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2023 |
-0.01 |
0.01 |
2022 |
-1.63 |
0.55 |
2021 |
-8.44 |
2.48 |
2020 |
-- |
-- |
2019 |
-- |
-- |
What is the 52 Week High and Low of Singular Genomics Systems Inc (OMIC)?
The 52-week high and low of Singular Genomics Systems Inc (OMIC) are Rs -- and Rs -- as of 28-Aug-2026.
What is the market cap of Singular Genomics Systems Inc (OMIC)?
Singular Genomics Systems Inc (OMIC) has a market capitalisation of $ 51 Mln as on 21-Feb-2025. As per SEBI classification, it is a Small Cap company.
Should I invest in Singular Genomics Systems Inc (OMIC)?
Before investing in Singular Genomics Systems Inc (OMIC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.